Skip to content
CA.gov logo in white
  • Grants Management System
  • CIRM Hub Portal
  • Contact
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops

Stem Cell Gene Therapy for Sickle Cell Disease

  • Post author:
  • Post published:July 5, 2026
  • Post category:

Sickle cell disease (SCD), which results from an inherited mutation in the hemoglobin gene that causes red blood cells to "sickle" under conditions of low oxygen, occurs with a frequency…

Continue ReadingStem Cell Gene Therapy for Sickle Cell Disease

iPS Cell-Based Treatment of Dominant Dystrophic Epidermolysis Bullosa

  • Post author:
  • Post published:July 5, 2026
  • Post category:

Genetic skin diseases constitute a diverse group of several hundred diseases that affect up to 2% of the population and include common disease such as psoriasis, atopic dermatitis, and wound…

Continue ReadingiPS Cell-Based Treatment of Dominant Dystrophic Epidermolysis Bullosa

Molecular Characterization of hESC and hIPSC-Derived Spinal Motor Neurons

  • Post author:
  • Post published:July 5, 2026
  • Post category:

One of the main objectives of stem cell biology is to create physiologically relevant cell types that can be used to either facilitate the study of or directly treat human…

Continue ReadingMolecular Characterization of hESC and hIPSC-Derived Spinal Motor Neurons

Use of human iPS cells to study spinal muscular atrophy

  • Post author:
  • Post published:July 4, 2026
  • Post category:

Spinal muscular atrophy (SMA) is one of the most common autosomal recessive disorders that cause infant mortality. SMA is caused by loss of the Survival of Motor Neuron (SMN) protein,…

Continue ReadingUse of human iPS cells to study spinal muscular atrophy

Studying neurotransmission of normal and diseased human ES cell-derived neurons in vivo

  • Post author:
  • Post published:July 4, 2026
  • Post category:

Stem cells, including human embryonic stem cells, provide extraordinary new opportunities to model human diseases and may serve as platforms for drug screening and validation. Especially with the ever-improving effective…

Continue ReadingStudying neurotransmission of normal and diseased human ES cell-derived neurons in vivo

Viral-host interactions affecting neural differentiation of human progenitors

  • Post author:
  • Post published:July 4, 2026
  • Post category:

Human cytomegalovirus (HCMV) is the major cause of birth defects, almost all of which are neuronal in origin. Approximately 1% of newborns are infected, and of the 13% that are…

Continue ReadingViral-host interactions affecting neural differentiation of human progenitors

Investigation of synaptic defects in autism using patient-derived induced pluripotent stem cells

  • Post author:
  • Post published:July 4, 2026
  • Post category:

Autism spectrum disorders (ASD) are a group of neurodevelopmental diseases that occur in as many as 1 in 150 children in the United States. Three hallmarks of autism are dysfunctional…

Continue ReadingInvestigation of synaptic defects in autism using patient-derived induced pluripotent stem cells

Molecular Mechanisms Underlying Human Cardiac Cell Junction Maturation and Disease Using Human iPSC

  • Post author:
  • Post published:July 4, 2026
  • Post category:

Heart disease is the number one cause of death and disability in California and in the United States. Especially devastating is Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC), an inherited form of…

Continue ReadingMolecular Mechanisms Underlying Human Cardiac Cell Junction Maturation and Disease Using Human iPSC

Cellular tools to study brain diseases affecting synaptic transmission

  • Post author:
  • Post published:July 4, 2026
  • Post category:

There is a group of brain diseases that are caused by functional abnormalities. The brains of patients afflicted with these diseases which include autism spectrum disorders, schizophrenia, depression, and mania…

Continue ReadingCellular tools to study brain diseases affecting synaptic transmission

Use of iPS cells (iPSCs) to develop novels tools for the treatment of spinal muscular atrophy.

  • Post author:
  • Post published:July 4, 2026
  • Post category:

Spinal Muscular Atrophy (SMA) is one of the most common lethal genetic diseases in children. One in thirty five people carry a mutation in a gene called survival of motor…

Continue ReadingUse of iPS cells (iPSCs) to develop novels tools for the treatment of spinal muscular atrophy.
  • Go to the previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 9
  • Go to the next page
  • Careers
  • Administrative & Financials
  • Accessibility

Subscribe to Receive CIRM News

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox. 

Sign Up
Facebook-f X-twitter Instagram Linkedin Youtube
  • Privacy Policy
  • ©2025 California Institute for Regenerative Medicine
  • Media Guidelines
  • Contact Us